G10K and B10K Initiatives Select PacBio SMRT Sequencing for Next Phase of Genome Projects

MENLO PARK, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced the Genome 10K (G10K) and Bird 10,000 Genomes (B10K) initiatives have invested in SMRT® Sequencing to be included as one of the technologies for the next phase of their vertebrate genome assembly programs. Prominent neurobiologist Erich Jarvis, one of the co-founders of the B10K project and a co-leader of the G10K initiative, has ordered two Sequel™ Systems, with plans for three additional units in conjunction with his new position at The Rockefeller University, and in a planned collaboration with the New York Genome Center.

Several other global leaders of the G10K and B10K consortia will also contribute use of their recently acquired PacBio® Sequel Systems toward their goal of creating de novo assembled vertebrate genomes, including Harris Lewin at UC Davis in the USA, Richard Durbin at the Sanger Institute in the UK, Gene Myers at the Max Planck Institute of Molecular Cell Biology & Genetics in Germany, and Guojie Zhang with affiliations at BGI in China and Denmark.

The G10K project was established in 2009 by a consortium of biologists and genome scientists, including Dr. Jarvis, Steve O’Brien of the Dobzhansky Center for Genome Bioinformatics, David Haussler and Beth Shapiro of the UC Santa Cruz Genome Institute, and Oliver Ryder of UC San Diego. Together they determined to sequence the genomes of 10,000 vertebrate species by 2020. The B10K project, launched in 2015 and co-led by Dr. Jarvis along with Dr. Zhang of BGI and Thomas Gilbert of the University of Copenhagen, is an initiative to generate representative draft genome sequences for all 10,500 bird species, also within the next five years.

Logo Header Menu